Follow
Chintal H. Shah
Chintal H. Shah
Verified email at umaryland.edu
Title
Cited by
Cited by
Year
Reliability and Validity of the Short-Form 12 Item Version 2 (SF− 12v2) Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the US …
CH Shah, JD Brown
Journal of Clinical Medicine 9 (3), 661, 2020
472020
PSY10 THE ECONOMIC BURDEN OF SICKLE CELL DISEASE IN THE UNITED STATES
J Huo, H Xiao, M Garg, C Shah, DJ Wilkie, A Mainous III
Value in Health 21, S108, 2018
382018
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality
CH Shah, RM Reed, Y Liang, Z Zafari
ERJ open research 7 (3), 2021
132021
Economic burden of comorbidities among COPD patients hospitalized for acute exacerbations: An analysis of a commercially insured population
CH Shah, E Onukwugha, Z Zafari, E Villalonga-Olives, J Park, JF Slejko
Expert Review of Pharmacoeconomics & Outcomes Research 22 (4), 683-690, 2022
92022
Examining factors associated with adherence to hormonal therapy in breast cancer patients
CH Shah, R Balkrishnan, V Diaby, H Xiao
Research in Social and Administrative Pharmacy 16 (4), 574-582, 2020
62020
Quantifying heterogeneity of physical and mental health-related quality of life in chronic obstructive pulmonary disease patients in the United States
CH Shah, RM Reed, E Villalonga-Olives, JF Slejko, MN Eakin, JY So, ...
Expert review of respiratory medicine 14 (9), 937-947, 2020
52020
Disparities in prescription of opioids among prostate cancer patients of various racial groups
CH Shah, H Xiao
Pain management 9 (3), 273-281, 2019
32019
Trends in Medicaid spending on inhalers in the United States, 2012-2018
F Sistani, RM Reed, CH Shah, Z Zafari
Journal of Managed Care & Specialty Pharmacy 27 (12), 1744-1749, 2021
22021
The state of use and utility of negative controls in pharmacoepidemiologic studies
Z Zafari, J Park, CH Shah, S dosReis, EF Gorman, W Hua, Y Ma, F Tian
American Journal of Epidemiology 193 (3), 426-453, 2024
12024
Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017–2018
CH Shah, RM Reed, L Wastila, E Onukwugha, M Gopalakrishnan, Z Zafari
Applied Health Economics and Health Policy 21 (6), 915-924, 2023
12023
Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008–2019
CH Shah, CV Dave
Diabetology & Metabolic Syndrome 14 (1), 179, 2022
12022
Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States
CH Shah, E Onukwugha
Expert Review of Pharmacoeconomics & Outcomes Research 22 (6), 1013-1020, 2022
12022
PRS5 Direct Medical and Mortality Related Costs Among COPD Patients in the United States, 2017-2018
C Shah, Z Zafari
Value in Health 24, S213, 2021
12021
Real-world changes in costs over time among patients in the United States with hereditary angioedema on long-term prophylaxis with lanadelumab
CH Shah, N Princic, KA Evans, BG Schultz
Journal of Medical Economics 26 (1), 871-877, 2023
2023
Onychoscopy of nail lesions in dermatological disorders: A cross-sectional observational study
A Sutaria, D Pol, K Dalave, MS Deora, YK Sharma, CH Shah
Indian Journal of Dermatology 68 (1), 45-52, 2023
2023
The Economic Burden of Chronic Obstructive Pulmonary Disease and Comparative Effectiveness of Maintenance Inhaler Medications in the United States
C Shah
2023
HTA193 Criteria for Value Assessment of Medication Adherence-Enhancing Interventions: Preliminary Results of a Systematic Review
T Agh, M Hiligsmann, I Jakab, C Beaudart, E Manias, B Borah, ...
Value in Health 25 (12), S334, 2022
2022
Trends in Medicaid spending on buprenorphine for treatment of opioid use disorder in Maryland, 2002-2020
CH Shah, D Qato, J Saini, Z Zafari
APHA 2022 Annual Meeting and Expo, 2022
2022
EE322 Direct Medical and Indirect Absenteeism Costs Among Working Adult ADHD Patients in the United States
C Shah, E Onukwugha
Value in Health 25 (7), S397, 2022
2022
PRS8 Economic Burden of Comorbidities Among COPD Patients Experiencing Acute Exacerbations: an Analysis of a Commercially Insured Population
C Shah, E Onukwugha, Z Zafari, EV Olives, JE Park, JF Slejko
Value in Health 24, S214, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20